Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arash O Naghavi

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Cureus|September 2, 2025
Treatment and Clinical Outcome of a Patient With Spindle Cell Rhabdomyosarcoma Harboring MEIS1-FOXO1 Gene FusionRebecca Mathew, Rachel K Voss, Arash O Naghavi, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|April 6, 2017
Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy dosesYazan A Abuodeh, Arash O Naghavi, Tzu-Hua Juan, et al.
Head & Neck|December 14, 2019
Alterations in genetic pathways following radiotherapy for head and neck cancerArash O Naghavi, Youngchul Kim, George Q Yang, et al.
Asian Journal of Urology|November 16, 2022
Updates in the use of radiotherapy in the management of primary and locally-advanced penile cancerAkshar Patel, Arash O Naghavi, Peter A Johnstone, et al.
Clinical Lung Cancer|October 1, 2018
Analysis of Relapse Events After Definitive Chemoradiotherapy in Locally Advanced Non-Small-Cell Lung Cancer PatientsG Daniel Grass, Arash O Naghavi, Yazan A Abuodeh, et al.
Clinical and Translational Radiation Oncology|March 18, 2020
Using the revised Edmonton symptom assessment scale during neoadjuvant radiotherapy for retroperitoneal sarcomaRussell F Palm, Heather S L Jim, David Boulware, et al.
Journal of Contemporary Brachytherapy|November 30, 2016
The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapyMichelle I Echevarria, Arash O Naghavi, Puja S Venkat, et al.
Cancer|January 16, 2019
The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data BaseRussell F Palm, Daniel E Oliver, George Q Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2017
Low-dose-rate Brachytherapy for Prostate Cancer in Low-resource SettingsMichelle I Echevarria, Arash O Naghavi, Yazan A Abuodeh, et al.
Brachytherapy|May 13, 2026
Training-oriented framework for brachytherapy treatment planning in soft tissue sarcomaCole Friedes, Anupam Rishi, Amarjit Saini, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Cureus|September 2, 2025
Treatment and Clinical Outcome of a Patient With Spindle Cell Rhabdomyosarcoma Harboring MEIS1-FOXO1 Gene FusionRebecca Mathew, Rachel K Voss, Arash O Naghavi, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|April 6, 2017
Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy dosesYazan A Abuodeh, Arash O Naghavi, Tzu-Hua Juan, et al.
Head & Neck|December 14, 2019
Alterations in genetic pathways following radiotherapy for head and neck cancerArash O Naghavi, Youngchul Kim, George Q Yang, et al.
Asian Journal of Urology|November 16, 2022
Updates in the use of radiotherapy in the management of primary and locally-advanced penile cancerAkshar Patel, Arash O Naghavi, Peter A Johnstone, et al.
Clinical Lung Cancer|October 1, 2018
Analysis of Relapse Events After Definitive Chemoradiotherapy in Locally Advanced Non-Small-Cell Lung Cancer PatientsG Daniel Grass, Arash O Naghavi, Yazan A Abuodeh, et al.
Clinical and Translational Radiation Oncology|March 18, 2020
Using the revised Edmonton symptom assessment scale during neoadjuvant radiotherapy for retroperitoneal sarcomaRussell F Palm, Heather S L Jim, David Boulware, et al.
Journal of Contemporary Brachytherapy|November 30, 2016
The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapyMichelle I Echevarria, Arash O Naghavi, Puja S Venkat, et al.
Cancer|January 16, 2019
The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data BaseRussell F Palm, Daniel E Oliver, George Q Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2017
Low-dose-rate Brachytherapy for Prostate Cancer in Low-resource SettingsMichelle I Echevarria, Arash O Naghavi, Yazan A Abuodeh, et al.
Brachytherapy|May 13, 2026
Training-oriented framework for brachytherapy treatment planning in soft tissue sarcomaCole Friedes, Anupam Rishi, Amarjit Saini, et al.
Pageof 7